PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Neutron Therapeutics LLC

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neutron ranks #29,584 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#29,584
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.4/100)
17.6
avg claims per patent
+67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29584 · US Corporation #29,584 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #29,584/49,997
  • PHOTO-FINISH Neuren Pharmaceuticals
  • CPC-NARROW H05H · 9 areas
  • INNOV-PAR 42.4/100
  • CLAIMS-RICH 17.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +67% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neuren Pharmaceuticals Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neutron’s 42.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Neutron

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Neutron's Innovation Score is 42.4/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Neutron?

Each dot is one of Neutron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neutron’s own 17.6 claims/patent is at or below the 19.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Neutron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 0510152025 Granted patents (volume) Avg claims / patent Neuren Pharmaceuticals Limited - 9, 20.33Neuren Pharmaceut…NeuroLutions, Inc. - 9, 19.33NeurolutionsNeuroVision Imaging, Inc. - 9, 19.44Neurovision Imagi…Neurocentria, Inc. - 9, 19.44NeurocentriaNew Ideas Manufacturing LLC - 9, 4New Ideas Manufac…New Standards Manufacturing Co. - 9, 14.44New Standards Man…NewMarket Pharmaceuticals LLC - 9, 15.67Newmarket Pharmac…NewSight Reality, Inc. - 9, 20.89Newsight RealityNeutron Therapeutics LLC - 9, 17.56Neutron Therapeut…
Neutron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neutron's grants concentrate

Neutron Therapeutics LLC is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2019. By volume, Neutron sits between Neuren Pharmaceuticals Limited and NewSight Reality, Inc..

Neutron's three-year grant acceleration

Neutron Therapeutics LLC shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Neutron's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Neutron holds 9 patents at rank #29,597, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Neutron

By rank, the assignees closest to #29,597 in granted patent volume.

Leaders in H05H (Plasma Technique)

Other assignees with the most granted patents in Neutron's primary technology class.

Neutron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201820192021202320242025 1
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Neutron Therapeutics LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 22.2%
2019 1 11.1%
2021 1 11.1%
2023 2 22.2%
2024 2 22.2%
2025partial year 1 11.1%

Which technologies does Neutron Therapeutics LLC patent most?

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neutron Therapeutics LLC's patent record in context - here's where to go next.

  • Neutron Therapeutics LLC's lead technology class is H05H (Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams), 88.9% of its portfolio - see every assignee active in that class. Explore H05H
  • Ranked #29,584 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Neutron Therapeutics LLC against Neuren Pharmaceuticals Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.